1. Home
  2. ALVOW vs MGIC Comparison

ALVOW vs MGIC Comparison

Compare ALVOW & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALVOW
  • MGIC
  • Stock Information
  • Founded
  • ALVOW N/A
  • MGIC 1983
  • Country
  • ALVOW Luxembourg
  • MGIC Israel
  • Employees
  • ALVOW 999
  • MGIC N/A
  • Industry
  • ALVOW Biotechnology: Biological Products (No Diagnostic Substances)
  • MGIC Computer Software: Prepackaged Software
  • Sector
  • ALVOW Health Care
  • MGIC Technology
  • Exchange
  • ALVOW Nasdaq
  • MGIC Nasdaq
  • Market Cap
  • ALVOW N/A
  • MGIC N/A
  • IPO Year
  • ALVOW N/A
  • MGIC 1991
  • Fundamental
  • Price
  • ALVOW $2.40
  • MGIC $13.05
  • Analyst Decision
  • ALVOW
  • MGIC Buy
  • Analyst Count
  • ALVOW 0
  • MGIC 1
  • Target Price
  • ALVOW N/A
  • MGIC $15.00
  • AVG Volume (30 Days)
  • ALVOW N/A
  • MGIC 48.6K
  • Earning Date
  • ALVOW N/A
  • MGIC 03-12-2025
  • Dividend Yield
  • ALVOW N/A
  • MGIC 3.40%
  • EPS Growth
  • ALVOW N/A
  • MGIC N/A
  • EPS
  • ALVOW N/A
  • MGIC 0.70
  • Revenue
  • ALVOW N/A
  • MGIC $535,482,999.00
  • Revenue This Year
  • ALVOW N/A
  • MGIC $4.29
  • Revenue Next Year
  • ALVOW N/A
  • MGIC $3.39
  • P/E Ratio
  • ALVOW N/A
  • MGIC $18.52
  • Revenue Growth
  • ALVOW N/A
  • MGIC N/A
  • 52 Week Low
  • ALVOW N/A
  • MGIC $9.51
  • 52 Week High
  • ALVOW N/A
  • MGIC $13.46
  • Technical
  • Relative Strength Index (RSI)
  • ALVOW N/A
  • MGIC 61.02
  • Support Level
  • ALVOW N/A
  • MGIC $12.43
  • Resistance Level
  • ALVOW N/A
  • MGIC $13.46
  • Average True Range (ATR)
  • ALVOW 0.00
  • MGIC 0.28
  • MACD
  • ALVOW 0.00
  • MGIC 0.04
  • Stochastic Oscillator
  • ALVOW 0.00
  • MGIC 75.21

About ALVOW Alvotech Warrant

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

Share on Social Networks: